News Quantified

FBIO – fortress biotech, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million [Yahoo! Finance]

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Fortress Biotech (FBIO) was downgraded by Zacks Research from "strong-buy" to "hold".

Fortress Biotech's Cyprium enters agreement to sell PRV for $205M [Yahoo! Finance]

Form 4 Fortress Biotech, Inc. For: Apr 01 Filed by: Jin David

Form 10-K Fortress Biotech, Inc. For: Dec 31

Form 8-K Fortress Biotech, Inc. For: Mar 31

Form 8-K Fortress Biotech, Inc. For: Mar 30

Form SCHEDULE 13D/A Fortress Biotech, Inc. Filed by: ROSENWALD LINDSAY A MD

Top News Gainers

3/16 Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights 21.1%

3/24 Fortress Biotech (NASDAQ: FBIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. 15.7%

11/10 Do Insiders Own Shares In Fortress Biotech, Inc. (NASDAQ:FBIO)? [Yahoo! Finance News] 15.3%

8/23 Form 424B3 Fortress Biotech, Inc. 14.6%

7/19 Form 4 Fortress Biotech, Inc. For: Jul 18 Filed by: ROSENWALD LINDSAY A MD 12.3%

1/16 Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease 11.1%

12/10 Form 3 Fortress Biotech, Inc. For: Aug 14 Filed by: Lorenz Kevin 10.0%

12/18 Fortress Biotech (NASDAQ: FBIO) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock. 8.0%

11/12 Form FWP Fortress Biotech, Inc. Filed by: Fortress Biotech, Inc. 7.9%

5/10 Q1/2019 3/31/2019 EPS -0.340 ZacksConsensus -0.580 ActVsEst 0.240 - Beat 7.9%

Top News Decliners

3/13 Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Rowinsky Eric K -18.6%

8/9 Form S-8 Fortress Biotech, Inc. -15.3%

5/10 Form 10-Q Fortress Biotech, Inc. For: Mar 31 -10.1%

3/7 As Bad as Rout Is, Most Investors See Recession as a Long Shot [Yahoo! Finance News] -9.5%

7/16 Fortress Biotech (NASDAQ: FBIO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -6.6%

2/1 Fortress Biotech (NASDAQ: FBIO) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -5.1%

1/13 Journey Medical Corporation Recaps 2019 Growth -4.0%

2/14 Form SC 13G/A Fortress Biotech, Inc. Filed by: Opaleye Management Inc. -2.7%

5/16 Fortress Biotech (NASDAQ: FBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. -2.6%

11/25 Fortress Biotech Announces Pricing of Series A Preferred Stock Offering -2.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day